GLP-1 Manufacturer Direct-Pay Programs: 2026 Pricing Snapshot
Published 2026-06-02 · Verified 2026-09-15 · License: CC BY 4.0 · Download JSON
Four FDA-approved GLP-1 manufacturer direct-pay and savings programs operating in the US as of September 2026. Pricing, eligibility, and access terms verified directly on manufacturer-operated websites. Free to use under Creative Commons Attribution.
| Program | Drug | Monthly USD | Model | Insurance required |
|---|---|---|---|---|
| NovoCare Pharmacy Self-Pay Novo Nordisk | Wegovy semaglutide | $349 | Cash-pay direct; new patients $199/mo for first 2 fills of 0.25 mg and 0.5 mg (through Dec 31, 2026); Wegovy HD 7.2 mg $399; Wegovy pill $149-299 by dose | No |
| Wegovy Savings Card Novo Nordisk | Wegovy semaglutide | $25 | Copay reduction; max savings $100/mo | Yes |
| LillyDirect Self-Pay Pharmacy Eli Lilly | Zepbound tirzepatide | $449 | Cash-pay direct; vials or KwikPen: 2.5 mg $299, 5 mg $399, 7.5-15 mg $449 if refilled within 45 days ($499-699 if not) | No |
| Zepbound Savings Card Eli Lilly | Zepbound tirzepatide | $25 | Copay reduction; single-dose pen only; max savings $100/mo and $1,300/yr; ends Dec 31, 2026 | Yes |
Eligibility detail
- NovoCare Pharmacy Self-Pay (Wegovy): US residents with valid prescription; no insurance required. Government-insured patients may pay the self-pay price outside their insurance
- Wegovy Savings Card (Wegovy): Commercial insurance with Wegovy coverage; excludes Medicare, Medicaid, TRICARE, VA
- LillyDirect Self-Pay Pharmacy (Zepbound): US residents with valid Zepbound prescription; no insurance required
- Zepbound Savings Card (Zepbound): Commercial insurance with Zepbound coverage; excludes Medicare, Medicaid, TRICARE, VA
Methodology
Pricing and eligibility verified directly from manufacturer-operated websites on the date listed in the verified_on field. We document only publicly-disclosed prices and eligibility criteria; we do not estimate, average, or extrapolate. Where program terms vary by drug, dose, or eligibility tier, each combination is recorded separately.
Editorial integrity: this dataset complies with our methodology and editorial policy. When manufacturer terms change, we will update this dataset and log the change. Historical snapshots remain available during request to [email protected].
Important notes
- Manufacturer direct-pay programs cannot be combined with insurance copay benefits.
- Savings cards (Wegovy, Zepbound) require commercial insurance — they reduce copay, not list price.
- All program terms subject to change without notice. Always verify directly on the manufacturer's site before purchase.
- This dataset does NOT include compounded GLP-1 pricing (503A pharmacies) — those are not FDA-approved formulations and vary significantly by pharmacy.
How to cite
WeighedHealth (2026). GLP-1 Manufacturer Direct-Pay Programs: 2026 Pricing Snapshot. Retrieved from https://weighedhealth.com/research/glp1-manufacturer-direct-pay-2026
Download raw data
/datasets/glp1-manufacturer-direct-pay-2026.json — JSON, ~3KB, license CC BY 4.0